TIRSEMA 44 is a combination GLP-1–based injectable that contains:

Tirzepatide 40 mg (dual GIP + GLP-1 agonist)

Semaglutide 4 mg (GLP-1 agonist)

It’s supplied as a pre-filled pen for subcutaneous injection and marked single-patient use only.

What it’s typically used for

This combo is generally used for:

Aggressive fat loss / appetite suppression

Improved insulin sensitivity

Reduced cravings & better satiety

Blood sugar control (off-label in many cases)